Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Authors / Helen Sammons

Helen Sammons

Dr Helen Sammons is Associate Professor of Child Health at the University of Nottingham, a trained Pediatric Clinical Pharmacologist and a Consultant Pediatrician at the Derbyshire Children's Hospital. Dr Sammons is current chair of the RCPCH Joint Medicines Committee.  She was part of the working group for the Nuffield Bioethics Foundation report - Children and clinical research: ethical issues. Her research interests include clinical drug trials in children and neonates (including the TINN and TINN 2 FP7 projects), safe and effective prescribing and the ethics of pediatric clinical trials. Her published work includes the ethical issues surrounding clinical trials and the European Legislation, safety in clinical trials, sedation for diagnostic imaging and prescribing assessment.

  • Contributions

Small Pharma

April 7, 2015

Legislation on pediatric medicines is sowing the seeds for a better future, but we must maintain momentum if children are to get the best possible care.

1 min read

Small Pharma

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.